Stay updated on Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial

Sign up to get notified when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a minor version update from v3.4.1 to v3.4.2. This change does not affect the study details or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-02-13T12:12:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The update is a site version change from v3.4.0 to v3.4.1; there are no changes to the study content, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T19:05:38.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The revision tag changes from v3.3.3 to v3.3.4; there are no visible changes to the study details page.
    Difference
    0.0%
    Check dated 2026-01-15T03:11:30.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Locations and affiliated centers updated: new sites in California, Massachusetts, New Mexico, Oregon, and Texas, plus UT Southwestern Medical Center added; some listings removed, and the page revision updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-24T12:17:32.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    Version update from v3.2.0 to v3.3.2 is visible. No substantive changes to the trial content or its display are evident in the screenshots.
    Difference
    0.0%
    Check dated 2025-11-25T11:52:27.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Removal of the government funding status notice banner; it does not affect the study details or the information presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:19:44.000Z thumbnail image

Stay in the know with updates to Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.